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LIM Homeodomain Transcription Factor Isl-1 Enhances
Follicle Stimulating Hormone- and Luteinizing
Hormone- Gene Expression and Mediates the
Activation of Leptin on Gonadotropin Synthesis
Yingjie Wu, Haoshu Luo, Jiali Liu, Duo Kang, Alan S. McNeilly, and Sheng Cui
State Key Laboratory of Agrobiotechnology (Y.W., H.L., J.L., D.K., S.C.), College of Biological Sciences,
China Agricultural University, Beijing 100193, People’s Republic of China; and Medical Research Council
Human Reproductive Sciences Unit (A.S.M.), Queen’s Medical Research Institute, University of
Edinburgh, Edinburgh EH164TJ, United Kingdom
The Lin-11, Isl-1, andMec-3 (LIM) homeodomain transcription factor Isl-1 has been reported to be
involved in pituitary development in the early stages of mouse embryogenesis. Our recent studies
have shown that Isl-1 is mainly located in the pituitary gonadotropes throughout pituitary devel-
opment and persists to adulthood. We still do not know the physiological functions of Isl-1 ex-
pression and its related mechanisms in the pituitary gland. The aim of the present study was to
examine the hypothesis that Isl-1 is involved in regulating pituitary gonadotropin hormone (FSH/
LH) production by activating FSH and LH gene expressions. We have shown that Isl-1 activates
FSHandLH subunit promoters andendogenousgene transcription in LT2 cells. In addition, Isl-1
overexpression significantly increased FSH synthesis and secretion but not LH. The actions of Isl-1
were not observedwhen the homeodomain or LIM1domains aremutated. This demonstrates that
Isl-1 induction of FSH and LH is by both direct and indirect binding of Isl-1 to DNA sequences.
Furthermore, Isl-1 expressional levelwasup-regulated in LT2 cells after exposure toGnRH, activin,
and leptin.However, RNA interference-inducedknockdownof Isl-1 significantly reduced theeffect
of leptin but did not obviously influence the stimulating effects of GnRHand activin on LH and FSH
production. In conclusion, the results demonstrate that theLIM-homeodomain transcription factor
Isl-1 functions to increase FSH/LH gene transcription, and mediates the effects of leptin on
gonadotropin synthesis. (Endocrinology 151: 4787–4800, 2010)
The pituitary gonadotropins, FSH and LH, are het-erodimeric glycoproteins composed of a common
-subunit (-glycoprotein hormone -subunit), and spe-
cific -subunits (FSH or LH). In males and females,
both these hormones are essential for gonadal function
including folliculogenesis, spermatogenesis, and gonadal
steroids and protein production in both sexes (1–3). Al-
though the structures of these hormones are known, the
mechanisms that regulate the synthesis and differential
secretion of FSH and LH are not fully understood (4).
It is generally thought that the secretion of GnRH from
the hypothalamus is key in regulating the gene expression
of the gonadotropin -subunits (5–7). GnRH increases
hormonal production by binding to its transmembrane
receptor. This binding increases intracellular calcium,
which stimulates protein kinase C to activate nuclear pro-
teins, includingMAPK family members (8, 9). In addition
toGnRH, the synthesis and secretionof gonadotropins are
also regulated by the stimulating and inhibiting actions of
estrogen and androgen (10) and peptides such as activin,
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inhibin (11, 12), leptin, and bone morphogenetic proteins
(13, 14).
Leptin is a protein hormone synthesized and secreted
mainly by adipocytes (14). In addition to its well-known
regulating effects on appetite and metabolism, leptin is
also vital in reproduction. Mutations in either the leptin
(14) or the receptor (15) genes results in infertility. Leptin
administration reverses reproductive abnormalities in lep-
tin-deficient (ob/ob) mice (16) and accelerates sexualmat-
uration and puberty in normal female (17) and transgenic
mice (18). Although it is generally thought that the hypo-
thalamus is a key site of action, the mechanism of leptin
action in the reproductive system remains elusive. Leptin
acts within the hypothalamus to stimulate GnRH release,
which then triggers the subsequent release of FSHandLH,
and stimulates the development and function of gonads
(19). However, it was shown that leptin’s action on the
hypothalamus-pituitary-gonadal (HPG) axis appears at
different levels of this axis (20, 21). Thepituitary is a direct
target of leptin action because leptin receptors are ex-
pressed in the pituitaries ofmany animals (22–26), and the
cell types expressing leptin receptors include gonado-
tropes. In addition, leptin induces a bell-shaped dose-re-
sponse curve of LH and FSH release from incubated an-
terior pituitaries in rats, pigs, and cattle (27–29), with
almost the same effect on release of LH asGnRH (28, 29).
These results suggest that leptin plays an additional role in
regulating fertility by directly modulating pituitary LH
and FSH synthesis and secretion. However, the pituitary
intracellular pathways responsible for this direct action
are still unknown. Studies have shown that leptin func-
tions through Janus tyrosine kinase (JAK)-signal trans-
ducer and activator of transcription (STAT) signals in
brain and other tissues (30–32).
The extrapituitary regulators, such as GnRH and ac-
tivin, modulate LH and FSH subunit gene expression
through a number of nuclear transcription factors. The
factors involved in LH transcription include steroido-
genic factor 1 (SF-1), early growth response protein 1
(Egr-1), paired-like homeodomain transcription factor
(Pitx)-1, p8, Sp1, andnuclear factorY (33, 34).FSH gene
expression ismediated by SF-1, nuclear factorY, activator
protein-1, LIM class of homeodomain protein-3 (Lhx3),
and Pitx class factors (34). The interplay among the dif-
ferent factors and genes are not fully understood.
The Lin-11, Isl-1, and Mec-3 (LIM)-homeodomain
(HD) transcription factor Isl-1 is comprisedof two tandem
LIM domains and a HD. The homeodomain with a helix-
turn-helix structure binds to regulatoryDNAsequences of
its target genes. The LIM domains are mainly involved in
protein-protein interactions that regulate the activity of
LIM-HD(35). Isl-1was originally shown to function as an
insulin gene enhancer binding protein (36). It plays critical
roles in cell determination, proliferation and differentia-
tion in the nervous system (37, 38), heart (39), and pitu-
itary gland (40). In mice, it is specifically expressed in the
pituitary pouch rudiment at early development stages
(41). Isl-1/mice fetuses die at approximately embryonic
day (E) 10 and the analysis at E9.5 demonstrates that the
oral pouch is small and primitive with a conspicuously
thinner wall (42). The exact function of Isl-1 on the fetal
pituitary development is still unclear because Isl-1 gene
knockout causes developmental anomalies in the whole
embryo (38), and pituitary cell differentiation happens
mainly after E12.5 in themouse (41).Our previous studies
have shown that Isl-1 is mainly localized in gonadotropes,
and Isl-1 expression parallels gonadotropic differentia-
tion throughout the development in the sheep fetus and
chicken embryo (43, 44). Additional studies should de-
termine whether Isl-1 functions to promote pituitary go-
nadotrope differentiation and/or hormone production by
activating FSH and LH genes.
The aims of the present study were to determine the
effect of Isl-1 on LH and FSH gene expression and
hormone production in gonadotropes and to identify
whether Isl-1 is involved inmediating the signal pathways
of GnRH, activin, and leptin in regulating LH and FSH
production. The results show that Isl-1 enhances FSH/
LH gene transcription and FSH production. It is out of
our expectation that Isl-1 is involved in mediating the sig-
nal pathway of leptin but probably not GnRH and activin
on gonadotropin production in LT2 cells.
Materials and Methods
Animals and tissue collections
Kunming male mice were raised in a controlled temperature
of 25 1 C on a 12-h light, 12-h dark cycle. The animal exper-
imentswereapprovedby theChineseAssociation forLaboratory
Animal Sciences. For immunohistochemistry, pituitary glands of
three postnatal day (D) 40 mice were separated and fixed in 4%
paraformaldehyde in PBS (pH 7.4) for 4 h at room temperature,
embedded in paraffin, and cut into 5-m sections. In dietary
manipulation experiments, 30malemice at 21Dwere randomly
divided into three groups. Mice in the high-fat diet group were
fed a diet containing 20% fat for 2 wk. The control and fasted
groups were fed a regular grain diet, but the fasted group was
starved for 48 h but with ad libitum drinking water. For deter-
mining serum leptin concentrations, the mice with dietary ma-
nipulation and normal mice aged 21 D (17  2 g), 40 D (24 
2 g), and 60 D (37 3 g) were anesthetized, and blood samples
were collected from the orbital sinus (n  6 for each group).
Serum was harvested and frozen at 20 C until RIA was con-
ducted. After blood was taken, the mice were killed by cervical
dislocation. Pituitaries were separated and divided into three
factions per group for RT-PCR.
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Immunohistochemistry (IHC) and
immunocytochemistry (ICC)
Pituitary sections were dewaxed, rehydrated, and treated
with 10% normal goat serum in PBS and incubated with rabbit
antirat LH (1:50; National Hormone and Peptide Program,
Torrance, CA) and rabbit antihuman FSH (1:50; Zymed, San
Francisco, CA) at 4 C for 12 h. The section was then incubated
with fluorescein isothiocyanate-labeled goat antirabbit IgG (1:
50; Scottish Antibody Product Unit, Carluke, UK) at room tem-
perature for 3 h. After washing three times with PBS, the slides
were observed under a fluorescence microscope (Leica Micro-
systems, Cambridge, UK) and photographed. Immunohisto-
chemistry for Isl-1 detection was performed as previously de-
scribed (43). The percentage of LH or FSH costaining for Isl-1
was counted.
For ICC, LT2 cells were fixed in 4% paraformaldehyde for
10 min and permeabilized with 95%methanol at20 C for 10
min and then blocked in 10% normal goat serum for 1 h. Sub-
sequently, Isl-1 in the LT2 cells was stained using the same
protocol as IHC.
Plasmid construction
The 226 to 7 bp (226LH) and 712 to 7 bp
(712LH) regions of the LH gene and 1836 to 56 bp
(1836FSH) region of FSH gene were amplified from mouse
genomic DNA by the PCR method using specific primers: LH-,
226 bp, 5-ACCTTGTTTCCCGTGCTT-3 and 5-TCTTGAT-
ACCTTCCCTACCTT-3; LH-, 712 bp, 5-GACCGAATTT-
GCCCAGTA-3 and 5-TCTTGATACCTTCCCTACCTT-3;
FSH-,1836bp, 5-ATATAAACATCCCATCTCCA-3 and5-
ATCAAGTGCTGCTACTCACC-3. The 620 FSH was ob-
tained from the1836FSHbyMflI restriction enzyme digestion.
These fragments were respectively inserted into the pGL3.0-basic
luciferase reporter vector (Promega,Madison,WI). The expression
vector formurine Isl-1pXJ40-myc-Isl-1vectorwaskindlyprovided
by Dr. Xinmin Cao (Institute of Molecular and Cell Biology, Sin-
gapore). The truncated mutants of Isl-1 were generated by restric-
tion enzyme digestion and PCR methods. The LIM1 deletion
(Lim1) lacks amino acids (aa) 18–70, whereas the LIM2 deletion
(Lim2) lacks aa 95–109 in the Isl-1 peptide, and Lim1 and -2
combines both deletions. The homeodomain mutated deletion
(Homo) lacks aa 193–213 in the Isl-1 homeodomain.
Cell culture and transient transfections
The mouse pituitary LT2 and human embryonic kidney
(HEK)-293T cells were cultured in 10% fetal bovine serum-
DMEM (Life Technologies, Inc.-Invitrogen, Carlsbad, CA) sup-
plementedwith100 IU/mlpenicillin and100g/ml streptomycin
and incubated at 37 C with 5%CO2. Transient transfections or
cotransfections were performed using Fugene HD or 6 transfec-
tion reagents (Roche Applied Science, Basel, Switzerland) ac-
cording to the manufacturer’s recommendations. All transfec-
tion experiments were performed at least three times.
Luciferase assays
LT2 cells plated in 24-well plates were transfected with the
Isl-1 expressionvector or control vector, LHorFSH luciferase
reporter vectors, and pTK-Ranilla vector (Promega) at a ratio of
10:4:1. Cells were harvested 24 h after transfection. Luciferase ac-
tivity was measured using a dual-luc assay kit (Vigorous, Beijing,
China) onaModulusmicroplate luminometer (TurnerBiosystems,
Sunnyvale, CA). The values shown by the fluc to rluc ratio were
normalized to an empty luciferase reporter control.
HEK293T cells were cotransfected with pSilencer3.0-H1-
Isl1ix (x indicates the targeted site) and pSilencer3.0-H1-shRNA
control vector, respectively, with psiCHECK-Isl-1 (Promega) to
estimate their interferential effects. Luciferase activity was mea-
sured 48 h later using a dual-luciferase reporter assay. Interfer-
ence efficiency of each pSilencer3.0-H1-Isl1ix was shown by its
rluc to fluc ratio to that of pSilencer3.0-H1-shRNA.
Radioimmunoassays
Transfected LT2 cells (6  105 per 60 mm flask) were cul-
tured in 10% fetal calf serum-DMEM for 24 h. Cell media were
then replaced by DMEM (3 ml/flask). Cells were further incu-
bated for 48 h before harvesting. In Isl-1 expression-interference
experiments, cells were subjected to 10 ng/ml rat recombined
leptin (Abcam, Cambridge, UK), 10 nM GnRH analog (Sigma-
Aldrich, St. Louis,MO), 25 ng/ml activinA (Peprotech, London,
UK) or an equal volume DMEM for another 24 h. The media
were then collected and the cells were lysed in 400l lysis buffer
for LHandFSHdeterminations. Cellular protein concentrations
were determined by bicinchoninic assay. Experiments were per-
formed four to six times. The hormone concentrationswere nor-
malized to the protein concentration.
LH, FSH, and leptin were analyzed using RIA reagents pro-
vided by the Beijing North Institute Biological Technology (Bei-
jing, China). The minimum detectable concentrations were 1
mIU/ml for FSH and LH and 0.45 ng/ml for leptin. For each RIA
the intra- and interassay coefficients of variation were less than
15% and less than 10%, respectively.
PCR and RT-PCR
Total RNA was extracted using Trizol, and cDNA was gener-
ated from 2 g RNA in a 25-l reaction mixture using Moloney
murine leukemia virus (Promega) according to the manufacturer’s
protocols. LH, FSH, and internal control glyceraldehyde-3-
phosphatedehydrogenase (GAPDH) geneexpressionwereassayed
byquantitativeRT-PCRusingprimers asdescribedpreviously (45–
47). Isl-1 primers were designed by Primer Express 3.0 (Ap-
plied Biosystems, Foster City, CA) and confirmed to amplify
a single product of the expected size via dissociation analysis
and gel electrophoresis. Its sequences are: sense, 5-AGT-
CATCCGAGTGTGGTTTC-3, antisense, 5-CATGCTGTT-
GGGTGTATCTG-3. Amplification was carried out on the ABI
PRISM7500 sequence detection system (Applied Biosystems), and
eachsamplewasassayedthree times induplicate.Therelativeabun-
danceof thegeneswasdeterminedusing theABIPRISM’s software.
Leptin receptors, the short form (OB-Ra) and the long form
(OB-Rb), were detected by PCR using primers as previous de-
scribed (48).Amplificationswere carried out onPCR instrument
(Bio-Rad, Hercules, CA) using the following protocol: 94 C for
5 min (one time); 94 C for 50 sec; 54 C for 30 sec; 72 C for 30
sec (35 times); 72 C for 10 min; and 4 C holding.
Western blot analysis
Western blots were performed as described previously (49).
Goat polyclonal Isl-1 antibody and mouse monoclonal GAPDH
antibody were purchased, respectively, from R&D (Minneapo-
lis, MN) and Ambion (Austin, TX). All experiments were per-
formed three times. For quantification, the membranes were
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FIG. 1. Isl-1 is expressed and associated with LH and FSH genes in the LT2 gonadotropes. Dual labeling of LH-Isl-1 (A–C) and FSH-Isl-1 (D–
F) were carried out in the anterior pituitary gland of mice. Green fluorescence shows the localization of LH (B) and FSH (E). Isl-1-positive cells in
the same field of the same slide were stained brown (A and D). On their respective right are merged images (C and F). Purple arrows denote
representative double-stained cells. Bar, 30 m. Three mice were examined in this experiment. A representative result is shown. G, ICC of Isl-1 in
the LT2 cells. Nuclear localizations of Isl-1 are stained dark brown. Bar, 30 m. H, Sequence analysis of mouse FSH and LH promoter regions
of 1000 to 50 bp from the transcriptional sites. The putative Isl-1 binding sites are underlined. Arrows indicate the start site and the direction
of transcription. Box sequences are primer binding sites of ChIP analysis. I, ChIP analysis. A cell aliquot before precipitation was designated as the
input sample. PCR amplified 234-bp (LH) or 401-bp (FSH) regions in the promoters, respectively. Egr-1 was used as a positive control in
precipitating the LH promoter. IgG is a negative control provided by the kit.
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FIG. 2. Isl-1 induces the expressions of LH and FSH genes and production of FSH. A and B, Effects of Isl-1 expression vectors on the transiently
transfected LH (A) and FSH (B) gene promoters fused to luciferase reporter genes. The empty luciferase vector (luci) was also transfected as a control.
The stimulating amount of Isl-1-induced luciferase activity is denoted in parentheses. The experiments were repeated three times. C–E, Isl-1 increased LH
and FSHmRNA levels. The pXJ40-myc-Isl-1 and control vectors were transfected into LT2 cells, respectively. Isl-1 protein (C), LHmRNA (D), and FSH
mRNA (E) levels were analyzed 6, 15, and 24 h later by Western blot and RT-PCR, respectively. The present data of each assay were normalized to
respective 6-h control (control vector transfected 6 h). Each sample was assayed three times in duplicate. E and F, Changes of LH (E) and FSH (F) levels
after transfection of Isl-1 expression vectors. The pXJ40-myc-Isl-1 and control vectors were transfected into LT2 cells, and concentration of LH and FSH in
the media (secretion) and in the cellular extracts (synthesis) were determined 72 h later by RIA. In the data shown, hormone concentration is normalized
to the corresponded protein concentration. Values are all means SEM from four to six separate experiments. *, P 0.05; **, P 0.01.
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scanned on AlphaImager 2200 (Alpha Innotech Corp., San Le-
andro, CA). The results were analyzed by densitometry.
For ERK and STAT3 analysis, membranes were blocked and
then incubated in 1:1000 diluted primary antibodies overnight at 4
C. The phosphorylated (p)-ERK1/2, p-STAT3, and total ERK1/2
antibodies were from Cell Signaling Technology (Beverly, MA).
The STAT3 antibody was from Santa Cruz Biotechnology (Santa
Cruz, CA). After incubation for 1–2 h with secondary antibodies
(horseradish peroxidase conjugated), immunoreactive bands
were visualized by chemiluminescence (Millipore, Bedford,
MA). In each case, the membrane was initially probed with the
antibody against the phosphorylated protein and then stripped
using a buffer containing 2% sodium dodecyl sulfate, 62.5 mM
Tris (pH 6.8), and 0.1 M 2-mercaptoethanol for 30 min at 50 C.
After washing, immunodetection was repeated using an anti-
body against the total protein.
Chromatin immunoprecipitation (ChIP)
ChIPwasperformedusingaChIPassaykit (ActiveMotif,Carls-
bad, CA) as previously described (50). Isl-1 antibody was from
R&D. Antibodies of nonspecific IgG and Egr-1 (Santa Cruz Bio-
technology)were used as negative and positive (only for LH) con-
trols, respectively. Some of the protein-DNA was not precipitated
but set aside for total chromatin examination (termed input). After
DNA was purified, the aimed sequence, from 226 to 7 of the
mouse LH gene and 687 to 286 bp of the FSH gene, was
amplified by PCR using the primer sequences of 226 LH see
Plasmid construction) and FSH-: 5-TACCATTGGCCCTA-
AAT-3 and 5-TTGGCGAACTCAGAATCCTT-3.
Statistical analysis
All data were analyzed using one-way ANOVA, followed by
Student’s t test. All values are expressed as means SEM. A P
0.05 was considered significant.
Results
Isl-1 is expressed in the pituitary and
gonadotrope-derived LT2 cells
IHC results showed Isl-1 expression in the mouse pi-
tuitary gland. Dual-staining and cell-counting results
showed that 645%(mean SEM) LH immunopositive
cells and746%(mean SEM) of FSH-immunopositive
cells expressed Isl-1 in the mouse pituitary (Fig. 1, A–F).
These data demonstrate that most gonadotropes express
Isl-1 in the mouse pituitary. ICC results confirmed that
Isl-1 was expressed in mouse gonadotrope-derived LT2
cells (Fig. 1G).
Isl-1 interacts with LH and FSH genes in LT2
cells
Sequence analysis showed that mouse FSH and LH
genes contain two putative Isl-1 response elements (AT-
TAG) between 1000 and 50 bp upstream from the
transcription sites (Fig. 1H). ChIP experiments were con-
ducted to determine whether Isl-1 binds to the regulatory
regions of endogenous LH and FSH genes in LT2
cells. The primers encompassing the ATTAG box were
used to detect LH and FSH promoter sequences in
genomicDNAprecipitation (Fig. 1H). A 234-bp region of
mouse LH promoter was amplified from Isl-1-immuno-
precipitatedDNAaswell as input chromatin and theDNA
recruited by the LH transcription factor Egr-1 (Fig. 1G,
top panel). A 401-bp FSH promoter sequence was also
generated from Isl-1 immunoprecipitate (Fig. 1G, bottom
panel). No PCR-amplified product was detectedwhen the
Isl-1 antibody was replaced by a nonspecific control an-
tibody or in the water-template control (Fig. 1G). Taken
together, these results confirm that Isl-1 interacts with the
promoters of both FSH and LH in gonadotropes.
FIG. 3. Isl-1 mutants regulate 712LH (A) and 620FSH (B)
promoter activities in LT2 cells. The same quantity of wild and
mutated Isl-1 expression vectors were cotransfected into cells with
712LH or 620FSH promoter reporter genes. Results are
expressed as a ratio of firefly luciferase to renilla luciferase and then
normalized to that of control. Lim1, LIM1 domain mutated; LIM2,
LIM2 domain mutated; Lim1 and 2, both LIM1 and LIM2 domain
mutated; Homo, homeodomain mutated. The experiments were
repeated three times. Data are shown as means  SEM. Significant
differences (P  0.05) are shown by different letters.
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Isl-1 increases FSH and LH promoter activity and
affects hormone production
To determine whether Isl-1 is involved in regulating
LH and FSH gene transcription, pXJ40-myc-Isl-1 was
transfected into LT2 cells with either LH or FSH pro-
moter-luciferase genes. A dual-luciferase reporter assay
showed that Isl-1 enhanced the promoter activities of
226LH and712LH about 2.5-fold (P 0.05) and
2.3-fold (P  0.01), respectively (Fig. 2A). 620FSH
and1836FSHwere also stimulated by Isl-1 about 6.1-
fold (P 0.01) and 1.9-fold (P 0.05), respectively (Fig.
2B). Meanwhile, Isl-1 overexpression did not change the
luciferase activity of pGL3.0-basic (P  0.05).
To determine whether the overexpression of Isl-1 af-
fects endogenous transcriptional activity of gonadotropin
-subunits, we examined variations of their mRNA levels
in pXJ40-myc-Isl-1- or control vector-transfected LT2
cells. Western blot results indicated that Isl-1 expression
did not increase until 15 and 24 h after transfection of
pXJ40-myc-Isl-1 (Fig. 2C). Correspondingly, both LH
and FSH transcripts were significantly elevated to about
1.5-fold at 15 and 24 h (P  0.01) but were not changed
at 6 h (P  0.05, Fig. 2, D and E). In contrast, there was
no change in LH or FSH transcripts in control vector-
transfected cells throughout (P  0.05, Fig. 2, D and E).
Although Isl-1 significantly increased both LH and
FSHmRNA levels,RIA results showed that Isl-1 resulted
in a significant increaseonly in intracellular (P0.01) and
released (P 0.05) FSH (Fig. 2G) but not LH (P 0.05,
Fig. 2F).
Isl-1 HOMO and LIM domains regulate FSH and
LH promoters’ activities
LIM-HD Isl-1 has one homeodomain and two sepa-
rated LIM domains, interacting with target DNAs and
proteins, respectively. To determine which domains are
involved in the observed regulation of LH and FSH
gene transcription in LT2 cells, four truncated forms of
Isl-1proteinwere constructed:Lim1,Lim2,Lim1and
2, andHomo.Activationof Isl-1 onboth712LH and
620FSHwas decreased (P 0.05, Fig. 3) when LIM1,
LIM1 and 2, or the homeodomain was mutated. In con-
trast, deletion of LIM2 alone did not significantly change
the stimulating effects of Isl-1, whether on 712LH or
620FSH (P  0.05, Fig. 3).
GnRH, activin, and leptin all increase the
expression levels of LIM-HD Isl-1
To determine the potential for Isl-1 to mediate the ef-
fects of GnRH, activin, and leptin on gonadotropins, we
determinedmRNA levels of Isl-1 in LT2 cells exposed to
GnRH, activin, and leptin using RT-PCR. After GnRH
treatment, there was a significant increase in the Isl-1
mRNA level at 1 h (P 0.01), which peaked at 3 h (P
0.01) and decreased thereafter to the control level by
24 h (P  0.05, Fig. 4A). In response to activin and
leptin, Isl-1 mRNA level increased by 3 h (P  0.05),
peaked at 12 h, and stayed for at least 24 h (P  0.01,
Fig. 4, B and C). These results suggest that the LIM-HD
transcription factor Isl-1 is potentially involved in go-
nadotropin-regulating effects of GnRH, activin, and
leptin in gonadotropes.
Knockdown of Isl-1 expression in the LT2 cells
To directly test the role of Isl-1, five short hairpin RNA
constructs targeting mouse Isl-1 gene (Fig. 5A) were de-
signed to inhibit Isl-1 expression in LT2 cells. Each con-
struct was screened individually for inhibiting the activa-
tion of the psiCHECK-Isl-1 luciferase in transient
transfection assays. pSilencer-H1-Isli891 was the best in-
hibitor, reducing Isl-1 expression by about 75%, whereas
Isli511 resulted in a 64% reduction. Isli521, Isli1138, and
Isli1288 resulted in a 49, 35, and 37% reduction, respec-
tively (Fig. 5B).
FIG. 4. The relative levels of Isl-1 mRNA levels in LT2 cells treated by GnRH (A), activin (B), and leptin (C) for different times. Cells were treated with 10
nM GnRH, 25 ng/ml activin, or 10ng/ml leptin for 3, 6, 12, and 24 h. mRNA levels of Isl-1 and reference gene, GAPDH, were determined by RT-PCR. Data
are shown as means SEM from three experiments in duplicate and normalized to their respective control. *, P 0.05; **, P 0.01.
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To assess the pSilencer-H1-Isli891-inhibiting effects in
gonadotropes, protein levels of Isl-1 were determined in
LT2 cells. Isl-1 protein levels in empty vectors and non-
treated cells did not change significantly (P  0.05) but
decreased about 40.2% (P 0.05, Fig. 5, C andD) in cells
transfected with pSilencer-H1-Isli891, confirming its ef-
ficacy of reducing Isl-1 expression.
Isl-1 is involved in leptin’s regulation of LH and
FSH synthesis
The intracellular and medium concentrations of LH
and FSH in Isl-1 knockdown and control cells were de-
termined after treatment with GnRH, activin, and leptin
to assess the role of Isl-1 in their functions.
In Isl-1 knockdown cells in the absence of GnRH, ac-
tivin, or leptin (Fig. 6, NT group), the levels of secreted
FSH decreased (P 0.05, Fig. 6B). There was no effect on
intracellular or secreted LH levels (P  0.05).
GnRH treatment caused a small increase of LH secre-
tion inLT2cells (P0.05), and Isl-1 knockdowndidnot
influence this change (P 0.05, Fig. 6A). Activin did not
change the levels of LH (P  0.05, Fig. 6A); however, it
significantly promoted both synthesized (P  0.05) and
secreted (P  0.01) FSH levels in wild-type cells, which
also were not changed by Isl-1 interference (P 0.05, Fig.
6B). In contrast, leptin increased intracellular LH (P 
0.05, Fig. 6A) and FSH (P 0.05, Fig. 6B) concentrations
in control vector-transfected cells. Both were significantly
(P  0.01 for LH, Fig. 6A; P  0.05 for FSH, Fig. 6B)
decreased in Isl-1 knockdown cells, indicating that Isl-1
mediates leptin regulation of LH and FSH synthesis.
Leptin induces Isl-1 expression by JAK-STAT
PCR results showed that both the OB-Ra and OB-Rb
forms of the leptin receptor are expressed in LT2 cells as
well as in mouse pituitary, hypothalamus, and ovary (Fig.
7A). We next examined leptin-stimulated signals in LT2
cells. Cultured cells were exposed to leptin for up to 60
min. Cell lysateswere immunoprecipitatedwith antiphos-
pho-STAT3 or antiphospho-ERK antibodies. The leptin-
dependent increases in STAT3andERKactivitywereboth
detectable at 5 min (Fig. 7B), followed by a sustained in-
crease from 5 to 60 min (Fig. 7B). These results indicate
that leptin activates both STAT3andERK signals in LT2
cells. In addition, leptin-induced expression of Isl-1
mRNA was blocked by both the JAK-selective tyrosine
kinase inhibitorAG490andSTATs’phosphorylation sup-
pressor parthenolide (P  0.05, Fig. 7D). In contrast,
PD98059, a specific antagonist of ERK1/2, did notmodify
the transcription level of Isl-1 inducedby leptin (P0.05).
Interestingly, PD98059 alone also increased basal Isl-1
expressions (P  0.05, Fig. 7D).
The relation of pituitary Isl-1 mRNA levels to
serum leptin concentration
To further identify the potential relationship of Isl-1
and leptin in vivo, we measured the pituitary Isl-1 mRNA
by RT-PCR and serum leptin levels by RIA in mice at
different ages and with different feeding patterns. The re-
sults showed that Isl-1mRNAincreased significantly from
FIG. 5. Silencing effects of Isl-1 interference vector. A, Sketch map
indicates the targeted sites of several Isl-1 interference vectors (named
pSilencer-H1-Islix) in the mouse Isl-1 cDNA. B, psiCHECK-Isl-1 was
transfected into HEK293T cells together with pSilencer-H1-Islix. Dual-
luciferase ratios were expressed as ratios of renilla luciferase to firefly
luciferase, and they were normalized to pSilencer-H1-shRNA control.
Data are shown as means  SEM from three repeated experiments.
*, P  0.05; **, P  0.01. C and D, Western blot analysis of Isl-1 protein
levels in LT2 cells transfected with pSilencer-H1-shRNA, pSilencer-H1-
Isli891, and nontreated cells (NT). GAPDH is blotted as an internal control.
The integrated density value (IDV) of Isl-1 and GAPDH products were
determined using the AlphaImager 2200 software package (Alpha
Innotech), and Isl-1 expressional levels were expressed according to
IDV. Data from three experiments were all normalized to the control
and are shown as means  SEM. Significant differences (P  0.05) are
shown by different letters.
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21 D to 60 D (P  0.05, Fig. 8A), whereas serum leptin
levels increased significantly only at 60 D (P  0.05, Fig.
8B). However, the changes of pituitary Isl-1 mRNA level
did parallel global leptin concentrations in dietary manip-
ulated mice, with both increasing significantly (P 0.01)
after feeding with the high-fat diet but were not signifi-
cantly (P  0.05) changed by starvation for 48 h (Fig. 8,
C and D).
Discussion
Isl-1 expression in the developing pituitary gland has been
reported in mice (41, 51), chicks (44, 52), and sheep (43).
The dominant cell types expressing Isl-1 in the pituitary
gland are the FSH- and LH-expressing gonadotropes.
Our present results agree with these findings and show that
Isl-1 is mainly expressed in pituitary gonadotropes of pre-
pubertal to adult mice and in gonadotrope-derived cell line,
LT2. The discovery that LT2 cells express Isl-1 provides
an in vitro tool for studying the transcriptional effect of Isl-1
on LH/FSH gene expression and hormone production.
Previous studies on the function of Isl-1 in the pituitary
have focused on the early stage of embryo development.
Isl-1 null mice embryos show developmental
anomalies at E9.5 anddie at E10 (38, 42), 2.5 d
before pituitary cell differentiation and hor-
mone production (41). Therefore, this Isl-1
gene-knockout animal model cannot be used
to study the function of Isl-1 in pituitary de-
velopment and hormone secretion. Upon that
premise, the present study switches to in vitro
study, to demonstrate the relationship of Isl-1
and gonadotropin.
First, we have shown that Isl-1 not only in-
creases both LH and FSH promoter activi-
ties but also elevates their mRNA levels about
1.5-fold. These changes in mRNA agree with
luciferase assay results, which indicated that
Isl-1 causes a similar stimulation on long-form
LH and FSH promoter genes, which are,
respectively, increased 2.3- and 1.9-fold. The
elevation of mRNA strongly indicates that
Isl-1probably affects synthesis and secretionof
gonadotropins by altering LH and FSH
gene expression, which should result in in-
creasedhormoneproduction.However, the re-
sults have shown that both synthesis and se-
cretion levels of FSH are increased by Isl-1 in
LT2 cells but not that of LH.
Differential responses of LH and FSH may
relate to their different synthesis and secretion
patterns. Indeed, the LH and FSH subunits
have quite distinct amino acid sequences and variable oli-
gosaccharide chains (53). Glycosylation of polypeptides is
a posttranslational event, which influences the rate of hor-
mone dimmer assembly (54) and thus synthesis. Further-
more, LH and FSH also exhibit different secretion pat-
terns. Previous studies in sheep have confirmed that LH is
stored in electron-dense granules within the gonadotrope
(55) associated with SgII (56–58), and FSH appears in
electron light granules, possibly associated with chromo-
graninA (57–59). The release and subsequent plasma con-
centrations of FSH appear more closely related to the
amount of FSH being produced within the gonadotrope,
and also to the levels of transcription of FSHmRNA (4).
In contrast the release of LH occurs via a regulated path-
waywith little relationship to the levels of transcription of
LH mRNA. This is probably why LH was not changed
by Isl-1, although the expression level of LHmRNAwas
up-regulated.
Similar to other LIM-HD transcription factors, Isl-1
contains two LIM domains and a HD. To study the roles
of these domains in regulating LH and FSH gene ex-
pression, we constructed four Isl-1 mutants. The results
showed that the HD is required for full Isl-1 transcrip-
FIG. 6. Isl-1 is involved in leptin regulation of gonadotropin synthesis. pSilencer-H1-
Isli891 and control vectors were transfected into LT2 cells, and after 48 h, 10 nM
GnRH, 25 ng/ml activin and 10 ng/ml leptin were respectively added 24 h before
harvest. The LH (A) and FSH (B) hormone concentration in media and cellular extracts
were determined by RIA, and the data are shown by hormone concentration
normalized to the corresponding cellular protein concentration. Values are means 
SEM from four to six separate experiments. Significant differences are indicated by
different letters (P  0.05). NT, Nontreated cells.
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tional activity on LH and FSH genes, suggesting that
Isl-1 directly interacts with LH and FSH DNA. ChIP
results confirmed that thebinding site of Isl-1probably lies
within the regionsof226 to7bpon theLHgenes and
687 to 286 bp on the FSH gene, although the exact
binding motifs requires further work. In addition, the full
transcriptional activity of Isl-1 does not occur when the
LIM1 domain is absent. This indicates that Isl-1 also in-
fluences LH and FSH transcription by interacting with
other proteins through LIM1. Isl-1 is capable of interact-
ing with Lhx3 and the LIM-interacting partners, Ldb1, to
form a trimer using its ligand-binding domain and LIM1
domains (60). Isl-1 also functions in synergy with other
transcription factors, such as SF-1 (51), hepatocyte nu-
clear factor-4 (61), and class B bHLH transcription fac-
tor, BETA2 (62). The specific associating proteins were
not identified in this study. Possibly, one of the reasons of
Isl-1’s different magnitude of the effect on the LH and
FSH promoter activities is related to different specific
transcription factor interactions, e.g. Lhx3 has been shown
to regulate FSH but notLH promoters (63). Collectively,
it is likely that the Isl-1-mediated regulation of theLH and
FSHpromoters incorporates severalmechanisms involving
both direct and indirect interactions.
More importantly, the regulatory effect on FSH syn-
thesis and secretion potentially extends the role of Isl-1 to
theHPGaxis.GnRH, steroids, and cytokines producedby
the hypothalamus and gonads possibly regulate the ex-
pression or activation of Isl-1 in the pituitary, thus in-
creasing FSH hormone production. Hormone measure-
ments demonstrate that GnRH induces LH but not FSH
secretion, and activin stimulates FSH but not LH secre-
tion, which is in agreement with previous studies (7, 45,
64). However, Isl-1 does not appear to have a close rela-
FIG. 7. Intracellular signals of leptin in up-regulating Isl-1 in the LT2 cells. A, Expressions of leptin receptor mRNAs in LT2 cells and several
tissues of the adult mouse. Lane 1, DNA ladder; lane 2, mouse hypothalamus; lane 3, mouse pituitary; lane 4, LT2 cell; lane 5, mouse ovary; lane
6, reverse transcriptase blank without Moloney murine leukemia virus. OB-Ra and OB-Rb products are, respectively, 237 and 446 bp. GAPDH is
used as a positive control. Experiments were repeated three times, and one representative is shown. B, Leptin activates ERK and STAT3 signals in
the LT2 cells. The LT2 cells were cultured with 10 ng/ml leptin for 0 (no treatment control), 5, 10, 20, 30, and 60 min, respectively, and then
total protein extracts were prepared. Levels of phosphorylated ERK, phosphorylated STAT3, total ERK, and total STAT3 proteins were detected by
Western blot. C, Changes of p-STAT3/STAT3 and p-ERK/ERK Levels. Data were calculated using integrated density value ratio of bands in B, which
were determined by AlphaImager 2200 (Alpha Innotech). D, The relative levels of Isl-1 mRNA in LT2 cells treated by leptin and several inhibitors.
Inhibitors were added 1 h before leptin. All inhibitors had a final concentration of 20 M. After 12 h exposure to leptin, Isl-1 expressions in each
group were determined by RT-PCR and then normalized to that of control. Data are shown as means  SEM from three repeated experiments.
Significance (P  0.05) is shown by different letters. NT, Nontreated cells; PTL, parthenolide.
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tionship with the function of GnRH and activin because
their regulatory effects on gonadotropin are not changed
by Isl-1 interference.This is reasonable becauseGnRHhas
been shown to directly regulate LH through Egr-1,
which synergizes with SF-1 and Pitx1 (65), and activin
regulates FSH synthesis by small mothers against decap-
entaplegic homolog (smad) 2/3, which acts directly on the
FSH promoter (66). However, GnRH and activin in-
crease Isl-1 expression, and the effects of GnRH and ac-
tivin on FSH and LHdo not rely on Isl-1. It is possible that
Isl-1may be involved in otherGnRH- and activin-induced
effects, e.g. cell proliferation, as shown in other cells or
tissues (67, 68). This requires further studies.
The results of the present study show that leptin stim-
ulates both FSH and LH synthesis in LT2 cells, in agree-
ment with some previous reports (27, 28, 69). However,
there are conflicting reports about the effect of leptin on
gonadotropins and theHPGaxis.Administrationof leptin
in vitro reduced LH and FSH secretion in the rat hemipi-
tuitary cultures (70) and failed to stimulate FSH in energy-
deprived rhesus monkeys (71). Furthermore, in the pres-
ence of sufficient energy stores, leptin did not alter
reproductive function (19). It is unclear why these dis-
crepancies in the effect of leptin occur. Itmay be due to the
differential effects of leptin in modulating the expression
of its own receptors. It may also be due to the dose de-
pendence of leptin. Indeed, the concentration of endoge-
nous leptin is at a comparatively high level in the animals
with sufficient energy stores, and this has been confirmed
in our results. Thus, leptin may already be acting at max-
imum. An overdose of leptin was demonstrated to be sig-
nificantly decreased the expressional levels of hypotha-
lamic OB-Rb (72). Furthermore, there is evidence that
leptin’s lack of effectiveness on the HPG axis may be due
to influences of other neuroendocrine peptides, like neu-
ropeptide Y, GnRH, and estrogen (73–75).
In the reproductive axis, leptin is known to activate
signaling via its long- and short-form receptors. And we
have now shown that both forms of the receptor are ex-
pressed in the hypothalamus, pituitary, and ovary in the
mouse, confirming a previous report (22). Studies in cattle
(23) and sheep (24) pituitaries have suggested thatmost of
FIG. 8. Changes of pituitary Isl-1 mRNA levels and serum leptin by age and diet. A and B, Pituitary Isl-1 mRNA levels and serum leptin
concentrations in mice 21, 40, and 60 d old. Isl-1 mRNA levels were determined by real-time PCR. GAPDH is a reference gene. Each sample was
assayed three times in duplicate. Present data of each assay was normalized to that of the 21 D group. The sample numbers for leptin
determination were n 	 6 (21 D), n 	 6 (40 D), and n 	 10 (60 D), respectively. C and D, Changes of pituitary Isl-1 mRNA levels and serum leptin
concentrations after 2 wk of dietary manipulation. The control group was fed a regular grain diet; the high-fat diet (HFD) group was fed a diet
containing 20% fat. Mice in the fast group were starved for the last 48 h with sufficient drinking water. The sample number for each group is 10.
Isl-1 mRNA levels were determined by real-time PCR. Each sample was assayed three times in duplicate and normalized to that of control group.
All of the data are shown as means  SEM. *, P  0.05; **, means P  0.01.
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OB-R-positive cells are gonadotropes. This agrees well
with present result that OB-Rs are expressed in LT2
gonadotropes.
The present work is the first to show, using specific
inhibitors, that Isl-1 mRNA levels are regulated by leptin
through JAK-STAT’s cascade in pituitary gonadotropes,
similar to the hypothalamus (76, 77). This, however, dif-
fers with a previous report that shows that leptin’s action
in the reproductive neuroendocrine axis is independent of
pSTAT3 signaling as shown by disrupting Tyr1138 phos-
phorylation in the OB-Rb (78). It has been reported that
JAK-stimulated Isl-1 could induce Tyr phosphorylation,
DNA binding activity, and target gene expression of
STAT3 independent of other activators (e.g. epithelial
growth factor) (79). This suggests that Isl-1 may function
as an adaptor protein that brings JAK and STAT3 into
proximity and thereby facilitates STAT3phosphorylation
by JAK. This fits well with our results, which indicate that
leptin elevates Isl-1 expression, resulting in the induction
of STAT3 phosphorylation. However, the inhibitor par-
thenolide used in our study is a broad inhibitor of phos-
phorylation of STATs, including STAT1, -3, -5, and -6.
We did not check the phosphorylation of other STATs,
whichmay have roles in the present study. This study also
shows that leptin activates the ERK pathway in LT2 go-
nadotrope cells. It is in agreement with the report that
leptin promotes proliferation via the MAPK/ERK signal
pathway in endometrial cancer cells (80). This suggests
that leptin may function to promote LT2 cell prolifera-
tionbyactivatingERK.Nevertheless, themolecularmech-
anismof leptin’s effect through STATs andMAPKneed to
be elucidated further.
In the present study, serum leptin rose from 40 D to 60
D, which agrees with a previous study that showed leptin
increases from 20D to postpuberty inmalemouse plasma
(81). The expression levels of pituitary Isl-1 also increased
over this time. This parallel change suggests that leptin is
an important determinative regulator for Isl-1 around pu-
berty. However, the changes in leptin and Isl-1 were not
completely consistent with serumLHand FSH levels (82).
This is probably related to the complex effects of other
regulators like activin, inhibin, and principally GnRH
during the prepubertal-pubertal transition. More impor-
tantly, our results also show that serum leptin and pitu-
itary Isl-1 display parallel changes under dietary manip-
ulations. This, together with the developmental results,
strongly supports the in vitro results demonstrating that
leptin regulates pituitary Isl-1 expression and reveals their
close physiological relationship in vivo.
In conclusion, this novel study demonstrates that Isl-1
not only increases the expression of LH and FSH -sub-
unit genes but also mediates the regulating functions of
leptin on LH and FSH synthesis.
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